Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 5:21 pm Purchase |
2021-12-31 | 13G | Immuneering Corporation IMRX |
Zeskind Benjamin J. | 3,357,279 12.700% |
3,357,279 (New Position) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Immuneering Corporation IMRX |
BlackRock Inc. BLK |
1,716,170 6.600% |
1,716,170 (New Position) |
Filing History |
| 2021-08-13 4:02 pm Purchase |
2021-08-03 | 13G | Immuneering Corporation IMRX |
Citadel Advisors LLC | 2,062,676 8.000% |
2,062,676 (New Position) |
Filing History |
| 2021-08-13 4:01 pm Purchase |
2021-08-03 | 13G | Immuneering Corporation IMRX |
Cormorant Asset Management LP | 2,252,628 8.830% |
2,252,628 (New Position) |
Filing History |
| 2021-08-11 2:56 pm Purchase |
2021-07-31 | 13G | Immuneering Corporation IMRX |
Merrin Investors LLC | 2,405,386 9.300% |
2,405,386 (New Position) |
Filing History |
| 2021-08-10 1:37 pm Purchase |
2021-07-31 | 13G | Immuneering Corporation IMRX |
T. Rowe Price Associates, Inc. | 3,036,982 12.400% |
3,036,982 (New Position) |
Filing History |